Rossari Biotech Ltd shares jump 4.2% as Q2 FY27 results announced
Why did Rossari Biotech Ltd shares jump today?
Rossari Biotech Ltd shares surged 4.2% on Monday morning, trading at ₹454.95 as of 09:12 AM. The sharp rally comes after the company announced its unaudited financial results for the second quarter and first half of FY27, delivering numbers that exceeded market expectations on multiple fronts. Investors responded positively to the company's record-breaking performance.
The specialty-chemicals manufacturer reported its highest-ever quarterly revenue of ₹697.6 crores for Q2 FY27, marking a solid 19% growth year-on-year. What has really excited the Street, however, is that the company also clocked its highest-ever quarterly EBITDA at ₹87.0 crores, up 20.9% on a year-on-year basis. EBITDA margins improved to 12.5%, rising by 20 basis points, signaling better operational efficiency and cost management. This combination of top-line growth and margin expansion has given investors confidence in the company's growth trajectory.
Rossari Biotech's Profit After Tax (PAT) for the quarter stood at ₹38.9 crores. While the PAT remained subdued compared to what the strong EBITDA numbers might suggest, the company attributed this to higher depreciation charges arising from recent investments, which are expected to support future growth. The market appears to be looking past the short-term depreciation impact and focusing instead on the company's record revenue and EBITDA performance, which reflects robust demand for its specialty-chemicals solutions across industries.
What does Rossari Biotech Ltd do?
Rossari Biotech Limited is a specialty chemicals manufacturer that provides intelligent and sustainable solutions to customers across industries. The company is publicly listed, trading under stock code 543213 on the BSE Limited and under the symbol ROSSARI on the National Stock Exchange of India Limited, both headquartered in Mumbai.
Operating from Mumbai, Rossari Biotech is led by a leadership team that includes Company Secretary and Head of Legal Parul Gupta, a member of the ICSI with membership number A38895. The company regularly communicates its financial results to the stock exchanges, having recently announced its unaudited financial performance for the quarter and half year ended September 30, 2026, reporting its highest-ever quarterly revenue and EBITDA.
Rossari Biotech Ltd Financials
In CroresRossari Biotech Ltd reported a revenue of ₹684.86 crores in the March 2026 quarter, which increased to ₹697.2 crores in the June 2026 quarter, indicating a modest quarter-on-quarter revenue growth of approximately 1.8%. However, the company's profit declined from ₹45.97 crores in March 2026 to ₹35.09 crores in June 2026, representing a decrease of roughly 23.7%. While the top line showed a slight uptick, the bottom line witnessed a notable dip during the same period, suggesting that despite generating higher sales, the company's profitability came under pressure in the June 2026 quarter, possibly due to increased costs or margin compression.
Rossari Biotech Ltd Shareholding Pattern
Promoter holding stands at 68.14% of the total share capital. Foreign Institutional Investors (FIIs) hold 1.84% stake in the company, while Domestic Institutional Investors (DIIs) hold 14.19%. Public shareholders hold the remaining 15.84% stake in Rossari Biotech Ltd.
Rossari Biotech Ltd FAQs
Q: Why did Rossari shares jump 4.2% today?
Press Release for Q2 FY27 Results. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Rossari Biotech Ltd?
As per the latest data, promoters hold 68.14% stake in Rossari Biotech Ltd, while FII holding stands at 1.84%. Domestic institutional investors hold 14.19%, and public shareholders account for 15.84% of the equity.
Q: What is the current stock price of Rossari Biotech Ltd?
Rossari Biotech Ltd shares are currently trading at ₹454.95, recording a gain of 4.2% from the previous close.
Q: What is the market capitalization of Rossari Biotech Ltd?
The company currently has a market capitalization of ₹2520.16 crore, reflecting its valuation in the Indian equity market.